B Brooks

1.9k total citations · 1 hit paper
47 papers, 1.5k citations indexed

About

B Brooks is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Nutrition and Dietetics. According to data from OpenAlex, B Brooks has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Biochemistry and 8 papers in Nutrition and Dietetics. Recurrent topics in B Brooks's work include Hormonal Regulation and Hypertension (10 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Fatty Acid Research and Health (5 papers). B Brooks is often cited by papers focused on Hormonal Regulation and Hypertension (10 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Fatty Acid Research and Health (5 papers). B Brooks collaborates with scholars based in United States, Canada and Australia. B Brooks's co-authors include E. E. Muirhead, Lawrence W. Byers, R. G. E. Murray, Merle L. Blank, Fred Snyder, James A. Pitcock, Muirhead Ee, Byron E. Leach, Pamela Brown and Wilton A. Rightsel and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

B Brooks

47 papers receiving 1.3k citations

Hit Papers

Antihypertensive activity of an alkyl ether analog of pho... 1979 2026 1994 2010 1979 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Brooks United States 18 578 316 276 272 254 47 1.5k
Stephen C. Benson United States 17 777 1.3× 168 0.5× 399 1.4× 341 1.3× 289 1.1× 23 1.8k
Lauren M. Cagen United States 21 734 1.3× 383 1.2× 155 0.6× 251 0.9× 326 1.3× 47 1.8k
Ira Rosenblum United States 21 498 0.9× 73 0.2× 167 0.6× 301 1.1× 102 0.4× 76 1.7k
Melvin Blecher United States 23 1.0k 1.8× 204 0.6× 77 0.3× 287 1.1× 430 1.7× 67 1.9k
I.T. Oliver Australia 22 911 1.6× 221 0.7× 161 0.6× 331 1.2× 439 1.7× 55 2.2k
Frank P. Bell Canada 23 537 0.9× 132 0.4× 143 0.5× 163 0.6× 278 1.1× 84 1.6k
Susan E. Barrow United Kingdom 23 287 0.5× 280 0.9× 293 1.1× 109 0.4× 299 1.2× 47 1.6k
Boyd Malone United States 26 1.0k 1.8× 625 2.0× 108 0.4× 148 0.5× 442 1.7× 42 2.2k
Tülay Akçay Türkiye 24 557 1.0× 163 0.5× 69 0.3× 228 0.8× 317 1.2× 63 1.7k

Countries citing papers authored by B Brooks

Since Specialization
Citations

This map shows the geographic impact of B Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Brooks more than expected).

Fields of papers citing papers by B Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Brooks. The network helps show where B Brooks may publish in the future.

Co-authorship network of co-authors of B Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of B Brooks. A scholar is included among the top collaborators of B Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Brooks. B Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Muirhead, E. E., David H. P. Streeten, Lawrence W. Byers, B Brooks, & E. Todd Schroeder. (1993). Lipomedullipinoma: A Source of Hypermedullipinemia. Blood Pressure. 2(3). 183–188. 3 indexed citations
3.
Muirhead, E. E., David H. P. Streeten, B Brooks, E. Todd Schroeder, & Lawrence W. Byers. (1992). Persistent Hypotension Associated with Hypermedullipinemia: A New Syndrome. Blood Pressure. 1(3). 138–148. 4 indexed citations
4.
Muirhead, E. E., B Brooks, & Lawrence W. Byers. (1992). Biologic Differences Between Vasodilator Prostaglandins and Medullipin I. The American Journal of the Medical Sciences. 303(2). 86–89. 7 indexed citations
5.
Muirhead, E. E., B Brooks, Lawrence W. Byers, Pamela Brown, & James A. Pitcock. (1991). SECRETION OF MEDULLIPIN I BY ISOLATED KIDNEYS PERFUSED UNDER ELEVATED PRESSURE. Clinical and Experimental Pharmacology and Physiology. 18(6). 409–417. 13 indexed citations
6.
Muirhead, E. E., Lawrence W. Byers, B Brooks, Pamela Brown, & James A. Pitcock. (1989). Biologic Contrasts Between Medullipin I and Vasoactive Glyceryl Compounds. The American Journal of the Medical Sciences. 298(2). 93–103. 9 indexed citations
7.
Muirhead, E. E., et al.. (1989). The renal antihypertensive endocrine function: its relation to cytochrome P-450. Journal of Hypertension. 7(5). 361–369. 13 indexed citations
8.
Muirhead, E. E., et al.. (1987). Rapid Communication: Selachyl Alcohol as an Oral Antihypertensive Agent: A Preliminary Note. The American Journal of the Medical Sciences. 294(5). 384–387. 1 indexed citations
9.
Pitcock, James A., Pamela Brown, B Brooks, et al.. (1985). The morphology and antihypertensive effect of renomedullary interstitial cells derived from dahl sensitive and resistant rats. Experimental and Molecular Pathology. 42(1). 29–43. 15 indexed citations
10.
Muirhead, E. E., James A. Pitcock, Alberto Nasjletti, Pamela Brown, & B Brooks. (1985). The antihypertensive function of the kidney. Its elucidation by captopril plus unclipping.. Hypertension. 7(3_pt_2). I127–35. 19 indexed citations
11.
Pitcock, James A., et al.. (1984). Morphometric Studies on the Rat Renal Papilla of Resistant and Sensitive Strains in Partial Nephrectomy Salt Hypertension. Journal of Hypertension. 2(4). 419–425. 3 indexed citations
12.
Muirhead, E. E., Lawrence W. Byers, Björn Folkow, et al.. (1983). Antihypertensive polar and neutral renopapillary lipids. Which is a hormone?. Hypertension. 5(6_pt_3). V61–5. 12 indexed citations
13.
Muirhead, E. E., Björn Folkow, Lawrence W. Byers, et al.. (1983). Cardiovascular effects of antihypertensive polar and neutral renomedullary lipids.. Hypertension. 5(2_pt_2). 23 indexed citations
14.
Muirhead, E. E., et al.. (1981). Antihypertensive lipids from the kidney: alkyl ether analogs of phosphatidylcholine.. PubMed. 40(8). 2285–90. 23 indexed citations
15.
Pitcock, James A., et al.. (1981). Degranulation of renomedullary interstitial cells during reversal of hypertension.. Hypertension. 3(6_pt_2). II–75. 18 indexed citations
16.
Muirhead, E. E., Lawrence W. Byers, D. M. Desiderio, et al.. (1981). Alkyl ether analogs of phosphatidylcholine are orally active in hypertensive rabbits.. Hypertension. 3(3_pt_2). I107–11. 26 indexed citations
17.
Muirhead, E. E., et al.. (1981). Derivation of Neutral Antihypertensive Lipid from Renal Venous Effluent in Rats. Clinical Science. 61(s7). 331s–333s. 3 indexed citations
18.
Muirhead, E. E., et al.. (1980). Antihypertensive action of captopril in angiotensin-salt hypertension.. PubMed. 104(12). 631–4. 6 indexed citations
19.
Prewitt, Russell L., Byron E. Leach, Lawrence W. Byers, et al.. (1979). Antihypertensive polar renomedullary lipid, a semisynthetic vasodilator.. Hypertension. 1(3). 299–308. 67 indexed citations
20.
Muirhead, E. E., Wilton A. Rightsel, Byron E. Leach, et al.. (1977). Reversal of hypertension by transplants and lipid extracts of cultured renomedullary interstitial cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(2). 162–72. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026